TL GENOMICS
TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.The company isolates fetal cells in maternal blood using a uniquely developed technology and examines the genome of the fetal cells, enabling noninvasive and definitive diagnosis of fetal chromosomal disease early in pregnancy.
TL GENOMICS
Industry:
Health Care Medical Device Task Management
Founded:
2015-01-01
Address:
Koganei, Tokyo, Japan
Country:
Japan
Website Url:
http://www.tlgenomics.com
Total Employee:
11+
Status:
Active
Contact:
+81-42316-1636
Total Funding:
3.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache
Similar Organizations
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
Neteera
Neteera developed an AI-powered sensing platform to reduce treatment failures & improve outcomes in health screening, diagnosis & treatment.
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
True Digital Surgery
True Digital Surgery builds a 3D digital surgery visualization platform that improves visualization for a wide range of surgical procedures.
Current Advisors List
Current Employees Featured
Founder
Investors List
SMBC Venture Capital
SMBC Venture Capital investment in Series B - TL Genomics
Nissay Capital
Nissay Capital investment in Series B - TL Genomics
DBJ Capital
DBJ Capital investment in Series B - TL Genomics
NEDO
NEDO investment in Series A - TL Genomics
Nissay Capital
Nissay Capital investment in Series A - TL Genomics
Official Site Inspections
http://www.tlgenomics.com
- Host name: 163-44-185-204.virt.lolipop.jp
- IP address: 163.44.185.204
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
